OKUR

OnKure Therapeutics Inc. Class A Common Stock (OKUR)

Stock · NASDAQ · Health Care

$2.11as of 10/16/2026

Price chart

Open in TradingView

Active signals

RSI Positive Divergence32.0%200 SMA Touch0.0%
Resistance level
$4.02
Industry
Biotechnology: Pharmaceutical Preparations

OKUR Signal Track Record

How signals performed across all stocks →

What OKUR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike36-4.2%42%
Bollinger Band Breakout28-6.3%46%
Bollinger Band Breakdown20+4.2%60%
200-Day Moving Average TouchActive now14-6.3%43%
Any 20-session window (baseline)-2.1%45%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About OKUR

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, in…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
45

Fundamentals

1-day range
$2.09$2.28
Market cap
$168.06M
P/E (trailing)
—
P/E (forward)
-1.40
EPS (trailing)
$-3.50
Dividend yield
—
Beta
0.19
Avg. volume
234.2K
52-week range
$2.13$5.38

Forecasts

4 analyst ratings

Buy 83%
Hold 17%
Sell 0%
1-year price forecast
High
$21
+897.6%
Median
$15
+612.6%
Low
$11
+422.6%

OnKure Therapeutics Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

  • OKUR
    OnKure Therapeutics Inc. Class A Common Stock
    $2.1
    ▼ 1.41%
    Market cap $168.06MP/E —
    $2.13$5.38
  • PEPG
    PepGen Inc. Common Stock
    $2.6
    ▲ 2.77%
    Market cap $166.70MP/E —
    $1.31$7.8
  • INDP
    Indaptus Therapeutics Inc. Common Stock
    $2.63
    ▼ 7.72%
    Market cap $166.55MP/E —
    $0.92$5.96
  • NKTX
    Nkarta Inc. Common Stock
    $1.8
    ▼ 6.74%
    Market cap $163.84MP/E —
    $1.7$3.72
  • ARCT
    Arcturus Therapeutics Holdings Inc. Common Stock
    $10.34
    ▼ 8.25%
    Market cap $172.81MP/E —
    $5.5$24.17
  • KRRO
    Korro Bio Inc. Common Stock
    $8.49
    ▼ 8.81%
    Market cap $174.80MP/E —
    $5.2$55.89
  • AARD
    Aardvark Therapeutics Inc. Common Stock
    $3.78
    ▼ 2.07%
    Market cap $159.75MP/E —
    $3.35$16.6

P/E shows — for peers not currently carrying a live signal of their own.

Insider Activity

Insider Actions →
Acquired
430.6K
Disposed
423.9K

Institutional Ownership

March 31, 2026

Total shares held
27.24M
Total value held
$112.37M
Institutional holders
47
Top holders this quarter
  • Unknown4.00M
  • Unknown2.84M
  • Unknown2.66M
  • Unknown2.43M
  • Unknown2.15M
  • Unknown1.98M
  • Unknown1.93M
  • Unknown1.84M
  • Unknown1.45M
  • Unknown1.20M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.